Similarly, the small molecule PKR activator BEPP exhibits anti-cancer properties in both pancreatic [95] and lung cancer models [96] and may offer an exciting opportunity for further pre-clinical evaluation in hematologic malignancies. The gene discussed is EIF2AK2; the disease is hematologic disorder.